Health & Diseases

Degenerative Myelopathy in Dogs: Symptoms, Progression, and Care

Degenerative Myelopathy (DM) is a progressive, incurable spinal cord disease that leads to gradually progressing hind leg weakness and ultimately complete paralysis in dogs. The disease progresses in stages: first coordination problems, then paresis, and finally complete paralysis—usually within 6–18 months of symptom onset.

Degenerative Myelopathy in Dogs: Symptoms, Progression, and Care

What is degenerative myelopathy in dogs?

Degenerative myelopathy (DM) is a progressive, incurable disease of the spinal cord that causes gradually worsening hind limb weakness in dogs, eventually leading to complete paralysis. The disease progresses in stages: first, coordination problems; then, paresis; and finally, complete paralysis—usually within 6 to 18 months of the onset of symptoms.

DM occurs primarily in middle-aged and older dogs (8 years and older) and is significantly more common in certain breeds: German Shepherd, Pembroke Welsh Corgi, Boxer, Chesapeake Bay Retriever, and Rhodesian Ridgeback. It is caused by a mutation in the SOD1 gene, which leads to oxidative stress in the nerve cells of the spinal cord.

Background + Scientific Context

Awano et al. (2009, Proceedings of the National Academy of Sciences, PubMed 19188595) identified a mutation in the SOD1 gene as the causative factor through genome-wide association analysis: The homozygous mutation (A/A) significantly increases the risk of developing the disease; heterozygous carriers (A/G) are carriers of the predisposition. The parallel to ALS in humans—where SOD1 mutations also cause progressive motor neuron disease—makes DM a scientific animal model.

Coates and Wininger (2010, Veterinary Clinics of North America, PubMed 20610034) described the diagnosis and clinical presentation: DM resembles a herniated disc but is not painful. Diagnosis is made by ruling out other causes (MRI, CSF)—definitive confirmation is only possible through postmortem histopathology. SOD1 genetic testing increases the likelihood of a diagnosis but does not confirm the disease—it indicates an increased risk.

Kathmann et al. (2006, Journal of Veterinary Internal Medicine, PubMed 16948579) investigated the effect of daily controlled physical therapy on survival in dogs with DM: Dogs receiving intensive daily physical therapy lived significantly longer—a median of 255 days versus 130 days without intensive therapy. Physical therapy does not slow the neurodegenerative process, but it preserves muscle strength and mobility for longer and measurably improves quality of life.

Vitomalia-Position

DM is one of the few conditions in which owners can directly influence their pet’s quality of life and life expectancy through consistent care. Physical therapy, support carts, mats, and a modified environment are not luxuries—they are the treatment. We reject the fatalistic attitude of “There’s nothing we can do”: A diagnosis of DM is not a reason to immediately euthanize the animal. It marks the beginning of intensive care.

When does degenerative myelopathy become a concern in dogs?

  • In older dogs with gradually worsening hind limb weakness and no signs of pain
  • For dog breeds known to be at risk (German Shepherds, Corgis, Boxers): preventive genetic testing is available
  • For differential diagnosis with a herniated disc: Pain is absent in DM, but present in a herniated disc
  • When planning long-term care: The need for care is steadily increasing
  • Breeding recommendation: Do not breed SOD1 carriers with other carriers

Practical application

Stages of DM progression:

Stadium Clinical presentation Nursing intervention
In Coordination disorder, hindlimb ataxia Start physical therapy, anti-slip protection
Second Paralysis, dragging of the paws Paw protection, support strap
Three Paralysis, urinary/fecal incontinence Wheelchair, regular bladder drainage
Fourth Front legs affected, dysphagia Palliative care, quality of life assessment

Proven measures: - Daily physical therapy: passive range-of-motion exercises, underwater treadmill, swimming - Non-slip mats in all walking areas - Dog wheelchair for stages II–III: restores mobility and prevents pressure sores - Emptying the bladder regularly if you have incontinence: helps prevent infections - Frequent veterinary checkups (every 4–6 weeks)

Common Mistakes & Myths

  • “My dog isn’t in pain, so it’s not a big deal.” DM is largely painless—this is not a sign that the disease is harmless, but rather of neurodegenerative loss. The absence of pain makes care easier, but it does not mean the disease is mild.
  • “Positive genetic test = dog will develop DM.” A positive SOD1 test indicates an increased risk, not a definite diagnosis. Many carriers never develop clinical symptoms.
  • “Physical therapy doesn’t help if the nerves are damaged.” Physical therapy doesn’t heal nerves, but it helps maintain muscle mass, coordination, and quality of life—and has been shown to prolong the mobile phase.

Current State of Research (2026)

SOD1 genetic testing is routinely available in Europe and is recommended for breeding dogs of high-risk breeds. Neuroprotective approaches (vitamin E, N, stem cells) are being researched, though there is no clear clinical evidence to support them. Rehabilitation medicine and underwater treadmill therapy remain the standard of care.

Frequently Asked Questions

How can I recognize degenerative myelopathy in dogs?

The first sign is usually unsteadiness or poor coordination in the hind legs—the dog “drags” its paws while walking. Unlike with a herniated disc, there are no signs of pain. Progressive hind-limb weakness in an older dog of a high-risk breed requires veterinary evaluation, including an MRI and, if necessary, genetic testing.

Can degenerative myelopathy in dogs be treated?

There is no curative treatment—the disease is incurable. Physical therapy, underwater treadmill therapy, and assistive devices (braces, wheelchairs) slow the loss of function and significantly improve quality of life. According to Kathmann (2006), intensive daily physical therapy doubles the time to complete paralysis.

How long do dogs with degenerative myelopathy live?

From the onset of symptoms, the median survival time without intensive physical therapy is approximately 130 days until euthanasia, and approximately 255 days with intensive daily therapy. Some dogs are supported with a wheelchair for 1–2 years if their quality of life remains high and they receive intensive care. The key factor is the individual assessment of quality of life.

Related terms

Sources & Further Reading

  1. Awano, T., Johnson, G. S., Wade, C. M., Katz, M. L., Johnson, G. C., Taylor, J. F., Perloski, M., Biagi, T., Blacklock, B., & Lindblad-Toh, K. (2009). Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences USA, 106(8), 2794–2799. https://pubmed.ncbi.nlm.nih.gov/19188595/

  2. Coates, J. R., & Wininger, F. A. (2010). Canine degenerative myelopathy. Veterinary Clinics of North America: Small Animal Practice, 40(5), 929–950. https://pubmed.ncbi.nlm.nih.gov/20610034/

  3. Kathmann, I., Cizinauskas, S., Doherr, M. G., Steffen, F., & Jaggy, A. (2006). Daily controlled physiotherapy increases survival time in dogs with suspected degenerative myelopathy. Journal of Veterinary Internal Medicine, 20(4), 927–932. https://pubmed.ncbi.nlm.nih.gov/16948579/

Wissenschaftliche Einordnung

Awano et al. (2009, Proceedings of the National Academy of Sciences, PubMed 19188595) identified a mutation in the SOD1 gene as a causative factor through genome-wide association analysis: The homozygous mutation (A/A) significantly increases the risk of disease; heterozygous carriers (A/G) are carriers. The parallel to ALS in humans — where SOD1 mutations also cause progressive motor neuron disease — makes DM a scientific animal model.

Coates and Wininger (2010, Veterinary Clinics of North America, PubMed 20610034) described the diagnostics and clinical picture: DM resembles a slipped disc, but is not painful. Diagnosis is made by excluding other causes (MRI, CSF) — definitive proof is only histopathological post mortem. The SOD1 gene test increases the probability of diagnosis but does not confirm the disease — it indicates an increased risk.

Kathmann et al. (2006, Journal of Veterinary Internal Medicine, PubMed 16948579) investigated the effect of daily controlled physiotherapy on survival time in DM dogs: Dogs with intensive daily physiotherapy lived significantly longer — a median of 255 days vs. 130 days without intensive therapy. Physiotherapy does not slow down the neurodegenerative process but maintains muscle strength and mobility longer and measurably improves quality of life.